Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Standard view
Full view
of .
Save to My Library
Look up keyword
Like this
0 of .
Results for:
No results containing your search query
P. 1
Advanced TF Russian Study Results W-graph 4ld

Advanced TF Russian Study Results W-graph 4ld



|Views: 508 |Likes:
Published by luis
article about this fantastic suplement
article about this fantastic suplement

More info:

Categories:Types, School Work
Published by: luis on Jan 03, 2009
Copyright:Attribution Non-commercial


Read on Scribd mobile: iPhone, iPad and Android.
download as DOC or read online from Scribd
See more
See less


The Study Results are in!
A Study Summary Report: 4Life Transfer Factor Advanced Formulas Increase Immune System Effectiveness
With two products—4Life Transfer Factor Classic and4Life Transfer Factor Plus—that already set new andhigher standards in immune system support—providing boosts in Natural Killer (NK) cell activity of 103 and 248 percent—how did 4Life think of trying to improve them? Itstarted with a dedication to the long-term pursuit of transfer factor research, which led to the discovery of eggs asanother viable source for transfer factors. A commitment toremain the leader in transfer factor technology and to provide the highest quality, most effective products for good health further drove 4Life to be even better. Andfinally, it came from the belief that one of the best ways toimprove 4Life Transfer Factor was to broaden the spectrumof support by combining safe and effective sources of transfer factors.4Life researchers and scientists developed the Transfer Factor E-XF™ proprietary blend in an effort to furthemaximize immune system support using transfer factor molecules. Transfer factors were taken from both the cowand chicken sources and combined in hopes of sparking asynergistic–effect which was definitely achieved.4Life Transfer Factor Advanced Formula and 4LifeTransfer Factor Plus Advanced Formula both feature thescientifically proven Transfer Factor E-XF proprietary blend. Developed exclusively by 4Life using patented and patent-pending technology, the E-XF blend calls upon theknowledge of two sources, providing an enhancedcombined effect of transfer factors from both cowcolostrum and chicken eggs. Research shows that theimmune building effects of this transfer factor blend aremore effective than that of colostrum or egg sources alone.In an effort to determine how powerful the 4Life Transfer Factor Advanced formulas are, researchers CalvinMcCausland, Ph.D and Emma Oganova, Ph.D, M.D.designed a study to test NK cell activity. Dr. AnatoliVorobiev at the Russian Academy of Medical Sciencedirected his team in the independent testing.
Using blindedcytotoxicity testing, cancerous cells were combined with NK cells from humans and divided into groups of NK cellsactivated with transfer factors and groups of unactivated NK cells.
Samples containing several different blends of transfer factors sourced from cow colostrum and egg yolks wereincubated with the NK cells for various time periods, in order to identify the most potent blend ratio and the optimalactivation time of NK cells to provide maximum health benefits. Comparison of times demonstrated that theactivation time of 48 hours promoted the greatest NK cellresponse.Results of this study conclusively demonstrated the ability of 4Life Transfer Factor Advanced Formula to boost NK cellactivity by 283 percent and of 4Life Transfer Factor PlusAdvanced Formula to propel NK cell activity to a remarkable437 percent above normal immune response (a responseestablished as a baseline from this study). They also showedthat 4Life Transfer Factor Classic increased NK cell activity by 204 percent when tested at a 48-hour activation time.Further, results from this scientific experiment showed that NK cells activated with 4Life Transfer Factor Plus AdvancedFormula killed 97 percent of cancerous cells, which exceededthe Interleukin-2 (IL2) activation kill rate of 88% during thesame time period.
The Russian scientists who conducted this study found theresults to be exceptional and requested further information sotheir results could be published in professional journals. Onescientist stated: “The 4Life sample [4Life Transfer FactoPlus Advanced Formula] activated NK cell activity more thanthe Interleukin-2 (IL2) drug used as the standard. Here, wenow refer to your sample as the Golden Interleukin,” said Dr.Kisielevsky, Russian Academy of Medical Sciences. Theseoutstanding test results are certain to be reflected in humanhealth through an increase in immune effectiveness, leadingto improved overall health. People around the world can beconfident in the ability of 4Life Transfer Factor AdvancedFormula and 4Life Transfer Factor Plus Advanced Formula tomore effectively modulate immune system function, makingit more response “able” and to provide broad-spectrumsupport that is unmatched in any other health supplementtoday.www.4lifediscovery.my4life.com
www.4lifediscovery.my4life.comSTUDY SUMMARy
To determine the extent to which Transfer Factor E-XF blends and 4Life Transfer Factor Plus Advanced Formula increases Natural Killer (NK) cell activity above baseline.
Study Design:
Dr. E. Oganova and Dr. C. McCausland designed the blinded cytotoxicity study.The independent testing of the coded samples was done under the direction of AcademicianAnatoly Vorobiev, M.D., Russian Academy of Medical Sciences (RAMS) and the experimentalwork was conducted by, Dr. M.V. Kisielevsky, Dr. E.O. Khalturina, at the Russian Cancer Research Center, RAMS.
Blood was obtained from RORC donor station. A standard method of densitygradient was used to isolate mononuclear cells [NK Cells]. The isolated cells, 60 thousandcells per well, in 100 ml of culture medium, were introduced into each well of Costar 96 wellplates. Then, portions of coded test samples [Transfer Factor E-XF blends of selected ratios,4Life Transfer Factor Plus E-XF blend and others samples] were introduced into the wells atpredetermined concentrations (wt./vol.). An Interleukin-2 (IL-2) standard was used to compareeffectiveness. The preparations were incubated in a CO
-incubator with a 5% CO
atmosphere,100% humidity and 37° C for 24 or 48 hours. Next 30 thousand K-562 tumor cells(erythroblastic human leukemia) were introduced into the wells. (Thus, the ratio of effector andtarget cells was 2:1. Each sample was tested in triplicate). The preparations containing boththe effector (NK cells) and target cells (K562 cancer cells) along with control wells were againincubated for 18-24 hours under the same incubator conditions. An MTT (dye) solution wasused to spectro-photometricly determine the number of viable cells remaining in each well.The cytotoxic index (CI) expressed in % is reported for each sample.
Each of the samples significantly increased NK cell activity. The Transfer Factor E-XF Blend (AdvancedFormula) resulted in greater NK cell activation (283%) than the Transfer Factor XF (204%). 4Life Transfer Factor PlusAdvanced Formula increased NK cell activity by 437%. The drug IL-2 increased NK cell active by 389%. In the study
activation by 4Life Transfer Factor Advanced Formula, 4Life Transfer Factor Plus Advanced Formula and IL-2 resulted ina kill rate of K562 cancer cells of 69%, 97% and 88% respectively with the 48-hour incubation period giving the greatestNK cell activation.
As a Result of These Tests 4Life® Transfer Factor™ Is Now Approved By the Health Ministry of Russia for use in Hospitals and Clinics! The 
First Ever Dietary Supplement to be approved for Useby Doctors and Hospitals in Russia
SANDY, UT (October 1, 2004) - 4Life announced today that 4Life Transfer Factor products as immunemodulators have been approved for use in hospitals and clinics in the Russian Federation.
Theresults of ten separate clinical trials and two experimental studies on 4Life Transfer Factor products werecombined in a Methodological Document that was approved by the Ministry of Health, which now allowsdoctors to recommend 4Life Transfer Factor Classic and 4Life Transfer Factor Plus® products to their patients. Transfer Factor is the
First Dietary Supplement Approved for Use by Doctors and Hospitalsin Russia
. The Russian Ministry of Health is the equivalent of the Food and Drug Administration in theUnited States. Doctors and scientists from Russia have been working jointly with scientists from 4Life for several years to arrive at this accomplishment. This approval establishes a new roll of dietary supplementsin the Russian health care system.
 Remarkable Response from Russian Academy of Medical Sciences
In another sector of research of 4Life Transfer Factor, Dr. Kisielevsky of the Russian Academy of MedicalSciences stated, “The 4Life sample [Transfer Factor Advanced Formula] activated NK (natural killer) cellactivity more than the Interleukin-2 (IL2) drug we used as the standard.” This discovery has attracted theattention of The International Scientific and Technical Center (ISTC) of Russia.
Scientists from Several Countries Join Forces for Additional Clinical Studies of Transfer Factor 
TheISTC of Russia is a member of a joint international project with other health agencies of Japan, Europe andthe US. The objective of the international project is to combine efforts in finding improvedimmunotherapies. Following the discoveries from the NK cell testing, the scientists of 4Life have beeninvited to join the project. 4Life Transfer Factor as an immune modulator will be further researched in thisinternational forum. The cost of the studies will be paid by the ISTC.
Worldwide Ramification
Speaking of this benchmark achievement, Dr. Calvin McCausland, VP of Research of 4Life, and Dr. Emma Oganova, 4Life/Eurasia President, jointly expressed that because of theacceptance by such a reputable organization and doctors from Russia and other major countries, 4LifeTransfer Factor will gain wider acceptance in the professional and private sectors as a superior immunesystem enhancing product. The worldwide ramifications to this acceptance are just beginning.4Life is theworld’s foremost leader in the development, production and distribution of natural immune support productsand were recently recognized by
magazine as the fifteenth fastest growing privately held company inAmerica. 
*We make no claims that our products will cure an illness. We suggest that you consult a physician if ill. The above statements have not been evaluated by the FDA or our company.www.4lifediscovery.my4life.com

Activity (3)

You've already reviewed this. Edit your review.
1 hundred reads
1 thousand reads
Gil Ricardo liked this

You're Reading a Free Preview

/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->